BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37129315)

  • 61. Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption.
    Li H; Torabi SJ; Park HS; Yarbrough WG; Mehra S; Choi R; Judson BL
    Laryngoscope; 2019 Aug; 129(8):1844-1855. PubMed ID: 30575965
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Speech-language pathology care and short- and long-term outcomes of oropharyngeal cancer treatment in the elderly.
    Webster KT; Tippett D; Simpson M; Abrams R; Pietsch K; Herbert RJ; Eisele DW; Gourin CG
    Laryngoscope; 2018 Jun; 128(6):1403-1411. PubMed ID: 29057504
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neck scar perception after neck dissection in HPV-associated oropharyngeal squamous cell carcinoma.
    Au VH; Miller LE; Mitchell MB; Larson AR; Lin DT; Feng AL; Richmon JD
    Am J Otolaryngol; 2024; 45(1):104074. PubMed ID: 37865986
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Salvage Transoral Robotic Surgery for Recurrent or Residual Head and Neck Squamous Cell Carcinoma: A Single Institution Experience.
    Dabas S; Dewan A; Ranjan R; Dewan AK; Shukla H; Sinha R
    Asian Pac J Cancer Prev; 2015; 16(17):7627-32. PubMed ID: 26625773
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Feasibility and safety of transoral robotic surgery (TORS) for early hypopharyngeal cancer: a subset analysis of the Hamburg University TORS-trial.
    Lörincz BB; Busch CJ; Möckelmann N; Knecht R
    Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):2993-8. PubMed ID: 25217079
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
    Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment modality impact on quality of life for human papillomavirus-associated oropharynx cancer.
    Xu MJ; Plonowska KA; Gurman ZR; Humphrey AK; Ha PK; Wang SJ; El-Sayed IH; Heaton CM; George JR; Yom SS; Algazi AP; Ryan WR
    Laryngoscope; 2020 Feb; 130(2):E48-E56. PubMed ID: 30919470
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Oncologic Outcomes Following Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Carcinoma in Older Patients.
    Parhar HS; Shimunov D; Newman JG; Cannady SB; Rajasekaran K; O' Malley BW; Chalian AA; Rassekh CH; Cohen RB; Lin A; Lukens J; Swisher-McClure S; Bauml J; Aggarwal C; Weinstein GS; Brody RM
    JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1167-1175. PubMed ID: 33119091
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Functional and survival outcomes in elderly patients undergoing transoral robotic surgery.
    Philips R; Topf MC; Crawley MB; Swendseid B; Luginbuhl A; Curry J; Cognetti D
    Oral Oncol; 2020 Dec; 111():104954. PubMed ID: 32827931
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of oropharyngeal squamous cell carcinoma: Is swallowing quality better after TORS or RT?
    Campo F; Iocca O; De Virgilio A; Mazzola F; Mercante G; Pichi B; Holsinger FC; Di Maio P; Ramella S; Pellini R
    Radiother Oncol; 2023 Jun; 183():109547. PubMed ID: 36813176
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Swallowing After Primary TORS and Unilateral or Bilateral Radiation for Low- to Intermediate-Risk Tonsil Cancer.
    Barbon CEA; Yao CMK; Peterson CB; Moreno AC; Goepfert RP; Johnson FM; Chronowski GM; Fuller CD; Gross ND; Hutcheson KA
    Otolaryngol Head Neck Surg; 2022 Sep; 167(3):484-493. PubMed ID: 34784256
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Swallowing and communication outcomes following primary transoral robotic surgery.
    Charters E; Wu R; Milross C; Bogaardt H; Freeman-Sanderson A; Ballard K; Davies S; Oates J; Clark J
    Head Neck; 2021 Jul; 43(7):2013-2023. PubMed ID: 33687115
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment Modality Impact on Patient-Reported Quality of Life in Human Papilloma Virus-Associated Oropharyngeal Carcinoma.
    Plonowska-Hirschfeld KA; Gulati A; Stephens EM; Ochoa E; Xu MJ; Ha PK; Heaton CM; Yom SS; Chan JW; Algazi A; Kang H; Ryan WR
    Laryngoscope; 2024 Apr; 134(4):1687-1695. PubMed ID: 37767815
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Risk factors for locoregional relapse after transoral robotic surgery for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Funk RK; Moore EJ; García JJ; Harmsen WS; Stoddard DG; Vencio EF; Foote RL; Price KA; Ma DJ
    Head Neck; 2016 Apr; 38 Suppl 1():E1674-9. PubMed ID: 26667985
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Outcomes of transoral laser microsurgery for oropharyngeal squamous cell carcinoma in Ireland and review of the literature on transoral approaches.
    Woods RSR; Geyer L; Ionescu A; Callanan D; Sheahan P
    Ir J Med Sci; 2019 May; 188(2):397-403. PubMed ID: 29926338
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Trends in Adjuvant Therapy After Surgery for Oropharyngeal Squamous Cell Carcinoma.
    Philips R; Sagheer H; Barsouk A; Swendseid B; Johnson J; Bar Ad V; Luginbuhl A; Curry J; Cognetti D
    Laryngoscope; 2022 Apr; 132(4):806-812. PubMed ID: 34553790
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Utility of video fluoroscopic swallow study in advancing oral diet post TORS for oropharyngeal malignancies.
    Hunter CJ; Romaniw NN; Beckham R; Farsi S; Benefield A; Solverson M; Gray EA; Nguyen E; Marshall A; King D; Sunde J; Moreno M; Vural E
    Am J Otolaryngol; 2024; 45(4):104336. PubMed ID: 38704947
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.
    Bhayani MK; Hutcheson KA; Barringer DA; Lisec A; Alvarez CP; Roberts DB; Lai SY; Lewin JS
    Head Neck; 2013 Nov; 35(11):1634-40. PubMed ID: 23322563
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
    Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Eapen L; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
    Lancet Oncol; 2019 Oct; 20(10):1349-1359. PubMed ID: 31416685
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Opioid Usage and Prescribing Predictors Following Transoral Robotic Surgery for Oropharyngeal Cancer.
    Abt NB; Holcomb AJ; Feng AL; Suresh K; Mokhtari TE; McHugh CI; Parikh AS; Faden DL; Deschler DG; Varvares MA; Lin DT; Richmon JD
    Laryngoscope; 2021 Jun; 131(6):E1888-E1894. PubMed ID: 33210756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.